Accès gratuit
Numéro
Med Sci (Paris)
Volume 17, Numéro 12, Décembre 2001
Page(s) 1260 - 1269
Section Articles de Synthèse
DOI http://dx.doi.org/10.1051/medsci/200117121260
Publié en ligne 15 décembre 2001
  1. Udagawa N, Takahashi N, Akatsu T, et al. Origin of osteoclasts : mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 1990; 87 : 7260–4.
  2. Ducy P, Schinke T, Karsenty G. The osteoblast : a sophisticated fibroblast under central surveillance. Science 2000; 289 : 1501–4.
  3. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin : a novel secreted protein involved in the regulation of bone density. Cell 1997; 89 : 309–19.
  4. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93 : 165–76.
  5. Teitelbaum S. Bone resorption by osteoclasts. Science 2000; 289 : 1504–8.
  6. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Sience 2000; 289 : 1508–14.
  7. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20 : 345–57.
  8. Franzoso G, Carlson L, Xing L, et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 1997; 11 : 3482–96.
  9. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13 : 2412–24.
  10. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12 : 1260–8.
  11. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397 : 315–23.
  12. Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000; 97 : 1566–71.
  13. Grigoriadis A, Wang Z, Cecchini M, et al. c-fos : a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266 : 443–8.
  14. Jochum W, David JP, Elliott C, et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 2000; 6 : 980–4.
  15. Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption : evidence for a low pH in resorbing lacunae and localization of a 100 kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 1985; 101 : 2210–22.
  16. Baron R, Neff L, Brown W, Courtoy PJ, Louvard D, Farquhar MG. Polarized secretion of lysosomal enzymes : co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol 1988; 106 : 1863–72.
  17. Baron R, Neff L, Roy C, Boisvert A, Caplan M. Evidence for a high and specific concentration of (Na+, K+)-ATPase in the plasma membrane of the osteoclast. Cell 1986; 46 : 311–20.
  18. Vaananen HK, Horton M. The osteoclast clear zone is a specialized cellextracellular matrix adhesion structure. J Cell Sci 1995; 108 : 2729–32.
  19. Salo J, Lehenkari P, Mulari M, Metsikko K, Vaananen HK. Removal of osteoclast bone resorption products by transcytosis. Science 1997; 276 : 270–3.
  20. Ali NN, Boyde Q, Jones SJ. Motility and resorption : osteoclastic activity in vitro. Anat Embryol 1984; 170 : 51–6.
  21. Lakkakorpi PT, Vaananen HK. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro. J Bone Miner Res 1991; 6 ; 817–26.
  22. Kanehisa J, Heersche JNM. Osteoclastic bone resorption : in vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 1988; 9 : 73–9.
  23. Marchisio PC, Cirillo D, Naldini MV, Teti A, Zambonin-Zallone A. Cell-subtratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J Cell Biol 1984; 99 : 1696–705.
  24. Teti A, Marchisio PC, Zambonin-Zallone A. Clear zone in osteoclast function : role of podosomes in regulation of resorbing activity. Am J Physiol 1991; 261 : C1-C7.
  25. Marchisio PC, Cirillo D, Teti A, Zambonin-Zallone A, Tarone G. Rous sarcoma virus-transfomed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytopkeletal proteins involved in microfilament-membrane interactions. Exp Cell Res 1987; 169 : 202–14.
  26. Lakkakorpi P, Tuukkanin J, Hentunun T, Jarvelin K, Vaananen K. Organization of osteoclast microfilaments during the attachment to bone surface in vitro. J Bone Miner Res 1989; 4 : 817–25.
  27. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion : RGD and integrins. Science 1987; 238 : 491–7.
  28. Horton MA, Davies J. Perspectives adhesion receptors in bone. J Bone Miner Res 1989; 4 : 803–7.
  29. King KL, D’Anza JJ, Bodary S, et al. Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J Bone Miner Res 1994; 9 : 381–7.
  30. McHugh KP, Hodivala-Dilke K, Zheng MH, et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000; 105 : 433–40.
  31. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P. Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 1993; 90 : 4485–9.
  32. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64 : 693–702.
  33. Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R. Osteoclasts express high levels of pp60 c-src in association with intracellular membranes. J Cell Biol 1992; 119 : 1003–13.
  34. Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors : dissociation from transcriptional activity. Cell 2001; 104 : 719–30.
  35. Sanjay A, Houghton A, Neff L, et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrinmediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001; 152 : 181–95.
  36. Schwartzberg PL, Xing L, Hoffmann O, et al. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src−/− mutant mice. Genes Dev 1997; 11 : 2835–44.
  37. Zhao W, Byrne MH, Boyce BF, Krane SM. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 1999; 103 : 517–24.
  38. Sims NA, Aoki K, Bogdanovich Z, et al. Impaired osteoclast function in Pyk2 knockout mice and cumulative effects in Pyk2/Src double knockout. J Bone Miner Res 1999; 14 (suppl 1) : S183.
  39. Tanaka S, Amling M, Neff L, et al. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 1996; 383 : 528–31.
  40. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 2000; 148 : 665–78.
  41. Yokouchi M, Kondo T, Sanjay A, et al. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem 2001; 276 : 35185–93.
  42. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989; 245 : 855–7.
  43. Chatterjee D, Neff L, Chakraborty M, et al. Sensitivity to vanadate and isoformes of subunits A and B distinguish the osreoclast proton-pump from other vacuolar H+-ATPases. Proc Natl Acad Sci USA 1992; 89 : 6257–61.
  44. Li J, Sarosi I, Yan XQ, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000; 97 : 1566–71.
  45. Li YP, Chen W, Liang Y, Li E, Stashenko P. Atp6i-deficient mice exhibit severe osteo-petrosis due to loss of osteoclastmediated extracellular acidification. Nat Genet 1999; 23 : 447–51.
  46. Scimeca JC, Franchi A, Trojani C, et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteos-clerotic (oc/oc) mutants. Bone 2000; 26 : 207–13.
  47. Frattini A, Orchard PJ, Sobacchi C, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25 : 343–6.
  48. Blair HC, Teitelbaum SL, Tan HL, Koziol CM, Schlesinger PH. Passive chloride permeability charge coupled to H+-ATPase of avian osteoclast ruffled membrane. Am J Physiol 1991; 260 : C1315–24.
  49. Kornak U, Kasper D, Bosl MR, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104 : 205–15.
  50. Teti A, Blair HC, Teitelbaum SL, et al. Cytoplasmic pH regulation and chloride bicarbonate exchange in avian osteoclasts. J Clin Invest 1989; 83 : 227–33.
  51. Ravesloot JH, Eisen T, Baron R, Boron W. Role of Na-H exchangers and vacuolar H+ pumps in intracellular pH regulation I neonatal rat osteoclasts. J Gen Physiol 1995; 105 : 177–208.
  52. Bekker PJ, Gay CV. Biochemical charcterization of an electrogenic vacuolar proton pump in purified chicken osteoclast plasma membrane vesicles. J Bone Miner Res 1990; 5 : 569–79.
  53. Chakraborty M, Chatterjee D, Gorelick FS, Baron R. Cell cycle-dependent and kinase-specific regulation of the apical Na/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin. Proc Natl Acad Sci USA 1994; 91 : 2115–9.
  54. Santhanagopal A, Chidiac P, Horne WC, Baron R, Dixon SJ. Calcitonin (ct) rapidly increases na(+)/h(+) exchange and metabolic acid production : effects mediated selectively by the c1a ct receptor isoform. Endocrinology 2001; 142 : 4401–13.
  55. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 1996; 2 : 1132–6.
  56. Reszka AA, Halasy-Nagy JM, Masarachia PJ, Rodan GA. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase. J Biol Chem 1999; 274 : 34967–73.